Adenovirus-mediated genetic manipulation of the myocardial beta-adrenergic signaling system in transplanted hearts.

OBJECTIVES Ex vivo perfusion of the cardiac allograft during organ procurement is an ideal environment for adenoviral vectors with transgenes that target improving graft contractility. One such target is the beta-adrenergic receptor-signaling system, in which alterations in transgenic mice have elucidated novel means to improve the function of the heart in vivo. The purpose of the current study was to determine the functional consequences of beta-adrenergic receptor manipulation in a rabbit model of cardiac allograft transplantation. METHODS New Zealand White rabbits weighing 3 kg served as recipients to 1-kg outbred donors. Donor hearts were arrested and harvested, and 1 of 3 adenoviral constructs was administered into the aortic root perfusing the graft. Transgenes delivered encoded either the human beta(2)-adrenergic receptor, a peptide inhibitor of beta-adrenergic receptor densensitization, or the marker transgene beta-galactosidase. RESULTS Five days after cervical heterotopic transplantation, left ventricular performance was measured on a Langendorff apparatus. A moderate pattern of rejection was seen in all grafts. Biventricular myocyte expression of beta-galactosidase was observed, and beta(2)-adrenergic receptor density was elevated 10-fold in grafts that received adeno-beta(2)-adrenergic receptor. Left ventricular systolic and diastolic performance was significantly increased in grafts transfected with either adeno-beta(2)-adrenergic receptor or adeno-beta-adrenergic receptor densensitization compared with control grafts that received adeno-beta-galactosidase. CONCLUSIONS Ex vivo adenovirus-mediated gene transfer is feasible in a rabbit allograft model and, more important, genetic manipulation of beta-adrenergic receptor signaling either by increasing beta(2)-adrenergic receptor density or blocking endogenous receptor desensitization improves graft function acutely in this allograft model.

[1]  R. Lefkowitz,et al.  Functional consequences of altering myocardial adrenergic receptor signaling. , 2000, Annual review of physiology.

[2]  R. Lefkowitz,et al.  Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function , 1999, Gene Therapy.

[3]  R. Lefkowitz,et al.  Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. , 1999, The Journal of clinical investigation.

[4]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Tenderich,et al.  Mechanical Circulatory Support after Orthotopic Heart Transplantation , 1998, The International journal of artificial organs.

[6]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Lefkowitz,et al.  CARDIAC AND PULMONARY REPLACEMENT EX VIVO ADENOVIRUS-MEDIATED GENE TRANSFER TO THE ADULT RAT HEART , 1998 .

[8]  R. Bolman.  Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. , 1998, The Journal of thoracic and cardiovascular surgery.

[9]  R. Lefkowitz,et al.  Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Koch,et al.  Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase* , 1997, The Journal of Biological Chemistry.

[11]  A. Berk,et al.  Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts: method and efficacy of adenovirus-mediated transduction. , 1997, The Journal of thoracic and cardiovascular surgery.

[12]  J. Benovic,et al.  G-protein-coupled receptor kinase activity is increased in hypertension. , 1997, The Journal of clinical investigation.

[13]  R. Lefkowitz,et al.  Restoration of b-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer , 1997 .

[14]  Yaozhong Ding,et al.  Gene Transfer of Transforming Growth Factor-β1 Prolongs Murine Cardiac Allograft Survival by Inhibiting Cell-Mediated Immunity , 1996 .

[15]  M. Lohse,et al.  Activation of β-Adrenergic Receptor Kinase During Myocardial Ischemia , 1996 .

[16]  J. Gaynor,et al.  Survival benefits of heart and lung transplantation. , 1996, Annals of surgery.

[17]  G. Couper,et al.  Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance. , 1996, Circulation.

[18]  H. D. Liggitt,et al.  Gene therapy for donor hearts: ex vivo liposome-mediated transfection. , 1996, The Journal of thoracic and cardiovascular surgery.

[19]  Willerson Jt.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995 .

[20]  H. Bittner,et al.  Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors. , 1995, The Annals of thoracic surgery.

[21]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[22]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[23]  R. Lefkowitz,et al.  Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. , 1994, The Journal of biological chemistry.

[24]  B. Liang,et al.  Reversible contractile dysfunction in reversible experimental cardiac allograft rejection: alterations in the beta-receptor-stimulated adenylylcyclase pathway. , 1993, The Journal of surgical research.

[25]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[26]  H. Mohri,et al.  Changes in myocardial beta-adrenergic receptors during acute rejection of heterotopically transplanted rat hearts. , 1992, The Journal of thoracic and cardiovascular surgery.

[27]  P. Hjemdahl,et al.  Development of myocardial beta-adrenergic receptor density and adenylate cyclase activity after human heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  M. Yacoub,et al.  The effect of orthotopic transplantation on total, beta 1- and beta 2-adrenoceptors in the human heart. , 1992, British journal of clinical pharmacology.

[29]  J. Gordon,et al.  Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. , 1989, Circulation.

[30]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[31]  K Ono,et al.  Improved technique of heart transplantation in rats. , 1969, The Journal of thoracic and cardiovascular surgery.